文献速递重症综合管理与镇静镇痛心脑血管急症

脓毒症诱导的心肌病中胆碱代谢相关特征生物标志物的识别与验证

IDENTIFICATION AND VERIFICATION OF FEATURE BIOMARKERS ASSOCIATED WITH CHOLINE METABOLISM IN SEPSIS-INDUCED CARDIOMYOPATHY.
PubMed 文献 · Shock · 2024-12-03
一句话结论生物信息学分析提示HIF-1α与脓毒症诱导的心肌病(SIC)患者生存显著相关(多因素COX分析),可能作为SIC早期检测与治疗干预的潜在生物标志物。

该研究基于GEO数据库芯片数据集GSE79962(20例SIC患者与11例健康对照),通过加权基因共表达网络分析、差异表达基因分析与胆碱代谢数据库取交集,获得HIF-1α、DGKD、PIK3R1共3个核心胆碱代谢基因,其中仅HIF-1α与死亡率显著相关(P=0.009)。按HIF-1α高、低表达行差异分析得到63个差异表达基因,构建蛋白互作网络获得CISH、THBS1、IMP1、MYC、SOCS3、VCAN共6个高优先级核心基因。多因素COX分析显示HIF-1α与SIC患者生存显著相关,并在体内、体外SIC模型中以免疫组化染色和qPCR验证。作者认为HIF-1α可能作为SIC早期检测与治疗干预的潜在生物标志物。

要点

  • 基于GSE79962数据集(20例SIC患者与11例健康对照)分析,获得HIF-1α、DGKD、PIK3R1共3个核心胆碱代谢基因,仅HIF-1α与死亡率显著相关(P=0.009)。
  • 按HIF-1α高、低表达行差异分析得到63个差异表达基因,蛋白互作网络筛出CISH、THBS1、IMP1、MYC、SOCS3、VCAN共6个高优先级核心基因。
  • 多因素COX分析显示HIF-1α与SIC患者生存显著相关,并经体内、体外SIC模型的免疫组化染色和qPCR验证。
  • 作者认为HIF-1α可能作为SIC早期检测与治疗干预的潜在生物标志物。

适用人群与场景

  • 脓毒症诱导的心肌病(SIC)患者:分析数据集为GSE79962,含20例SIC患者与11例健康对照。

研究设计与关键结果

  • 研究类型为基于GEO数据库芯片数据集GSE79962(20例SIC患者与11例健康对照)的生物信息学分析,并以体内、体外SIC模型进行实验验证。
  • 加权基因共表达网络分析识别出1个核心基因模块和3867个核心基因,与差异表达基因及胆碱代谢基因取交集获得3个核心胆碱代谢基因:HIF-1α、DGKD、PIK3R1。
  • 3个核心胆碱代谢基因中仅HIF-1α与死亡率显著相关(P=0.009)。
  • 基于HIF-1α高、低表达的差异分析得到63个差异表达基因,经Cytoscape构建蛋白互作网络获得6个高优先级核心基因:CISH、THBS1、IMP1、MYC、SOCS3、VCAN。
  • 多因素COX分析显示HIF-1α与SIC患者生存显著相关,并经体内、体外实验验证。

证据类型、等级与局限

  • 证据类型:基于公共芯片数据集的生物信息学分析,辅以体内、体外SIC模型的免疫组化染色和qPCR验证。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为HIF-1α可能作为SIC早期检测与治疗干预的潜在生物标志物。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Sepsis-induced cardiomyopathy ( SIC ), one of the most common complications of sepsis, seriously affects the prognosis of critically ill patients. Choline metabolism is an important biological process in the organism, and the mechanism of its interaction with SIC is unclear. The aim of this study was to reveal the choline metabolism genes (CMGs) associated with SIC and to provide effective targets for the treatment of SIC . Methods: Through a comprehensive analysis of the microarray dataset GSE79962 (comprising 20 SIC patients and 11 healthy controls) from the GEO database, suspected co-expression modules and differentially expressed genes (DEGs) in SIC were identified. Hub CMGs were obtained by intersecting choline metabolism database with DEGs and key model genes. Afterward, hub CMGs most significantly involved in prognosis were further analyzed for the verification of major pathways of enrichment analysis. Finally, the expression of hub CMGs in in vivo and in vitro SIC model was verified by immunohistochemistry staining and quantitative real-time polymerase chain reaction analysis (qPCR). Results: Weighted gene co-expression network analysis identified 1 hub gene panel and 3,867 hub genes, which were intersected with DEGs and CMGs to obtain the same 3 hub CMGs:HIF-1α, DGKD, and PIK3R1. Only HIF-1α shows significant association with mortality ( P = 0.009). Subsequent differential analysis based on the high and low HIF-1α expression yielded 63 DEGs and then they were uploaded into Cytoscape software to construct a protein-protein interaction network and 6 hub genes with the highest priority were obtained (CISH, THBS1, IMP1, MYC, SOCS3, and VCAN). Finally, a multifactorial COX analysis revealed a significant correlation between HIF-1α and survival in SIC patients, which was further validated by in vitro and in vivo experiments. Conclusion: Our findings will provide new insights into the pathogenesis of SIC , and HIF-1α may have important applications as a potential biomarker for early detection and therapeutic intervention in SIC .

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Pei MQ, Sun ZD, Yang YS, et al. IDENTIFICATION AND VERIFICATION OF FEATURE BIOMARKERS ASSOCIATED WITH CHOLINE METABOLISM IN SEPSIS-INDUCED CARDIOMYOPATHY. Shock. 2024. PMID: 39637364. doi:10.1097/SHK.0000000000002513

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。